Your browser doesn't support javascript.
loading
A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma.
Windon, Annika L; Loaiza-Bonilla, Arturo; Jensen, Christopher E; Randall, Michael; Morrissette, Jennifer J D; Shroff, Stuti G.
Affiliation
  • Windon AL; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Loaiza-Bonilla A; Medical Oncology, Cancer Treatment Centers of America, Philadelphia, PA, USA.
  • Jensen CE; Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Randall M; Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Morrissette JJD; Center for Personalized Diagnostics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Shroff SG; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
J Gastrointest Oncol ; 9(1): 1-10, 2018 Feb.
Article in En | MEDLINE | ID: mdl-29564165
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Prognostic_studies Language: En Journal: J Gastrointest Oncol Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Prognostic_studies Language: En Journal: J Gastrointest Oncol Year: 2018 Document type: Article Affiliation country: Country of publication: